Education
About Us
Working with TipRanks
Follow Us
Australian Clinical Labs Ltd (AU:ACL)
ASX:ACL
RESEARCH TOOLSreports
Total Valuation
Australian Clinical Labs Ltd has a market cap or net worth of AU$589.75M. The enterprise value is AU$781.76M.
Market CapAU$589.75M
Enterprise ValueAU$781.76M
Share Statistics
Australian Clinical Labs Ltd has 198.57M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding198.57M
Owned by Insiders<0.01%
Owned by Instutions
Financial Efficiency
Australian Clinical Labs Ltd’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per EmployeeAU$175,806.735
Profits Per EmployeeAU$5,389.796
Employee Count4,900
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Australian Clinical Labs Ltd is ―. Australian Clinical Labs Ltd’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Australian Clinical Labs Ltd had revenue of AU$861.45M and earned AU$26.41M in profits. Earnings per share was AU$0.13.
RevenueAU$861.45M
Gross ProfitAU$255.47M
Operating IncomeAU$166.63M
Pretax IncomeAU$40.27M
Net IncomeAU$26.41M
EBITDA140.88M
Earnings Per Share (EPS)0.13
Cash Flow
In the last 12 months, operating cash flow was AU$196.36M and capital expenditures -AU$8.42M, giving a free cash flow of AU$187.94M billion.
Operating Cash FlowAU$196.36M
Free Cash FlowAU$187.94M
Free Cash Flow per ShareAU$0.95
Dividends & Yields
Australian Clinical Labs Ltd pays an annual dividend of AU$0.13, resulting in a dividend yield of 4.21%
Dividend Per ShareAU$0.13
Dividend Yield4.21%
Payout Ratio54.22%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.88
52-Week Price Change25.85%
50-Day Moving Average3.23
200-Day Moving Average3.20
Relative Strength Index (RSI)45.49
Average Volume (3m)1.16M
Important Dates
Australian Clinical Labs Ltd upcoming earnings date is Aug 20, 2025, After Close.
Last Earnings DateFeb 25, 2025
Next Earnings DateAug 20, 2025
Ex-Dividend DateMar 27, 2025
Financial Position
Australian Clinical Labs Ltd as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Australian Clinical Labs Ltd has paid AU$13.49M in taxes.
Income TaxAU$13.49M
Effective Tax Rate―
Enterprise Valuation
Australian Clinical Labs Ltd EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Australian Clinical Labs Ltd has AU$26.84M in cash and marketable securities with AU$308.90M in debt, giving a net cash position of AU$282.05M billion.
Cash & Marketable SecuritiesAU$26.84M
Total DebtAU$308.90M
Net CashAU$282.05M
Net Cash Per ShareAU$1.42
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Australian Clinical Labs Ltd is AU$3.65, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$3.65
Price Target Upside22.90%
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast7.80%
EPS Growth Forecast99.87%